Novo Nordisk issues voluntary nationwide recall of Levemir ®, Tresiba ®, Fiasp ®, Novolog ® and Xultophy ® product samples due to improper storage temperature conditions. [ press release ].

DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Insulin Storage Devices Market (2020-2025) by Product, Patient Type, Insulated Kit Type, Geography, Competitive Analysis and the Impact of Covid-19 ...

Prefilled Smart Insulin Pens – Disposable pens preloaded with insulin, ideal for users seeking convenience. By Connectivity: Bluetooth-Enabled Smart Pens – Offer seamless data transfer and app ...

The smart insulin pens market is projected to reach USD 4,606.3 million by 2025 and is expected to grow steadily at a CAGR of 8.3% to reach USD 10,224.3 million by 2035. ... As these devices rely ...

March 3, 2009 — On February 26, sanofi-aventis announced that a prefilled disposable pen containing insulin glulisine (Apidra SoloSTAR) was approved by the US Food and Drug Administration (FDA ...

The global insulin-pen market is projected to grow to $41 billion by 2030 from about $34 billion in 2025, according to market research firm Mordor Intelligence.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections.

Ypsomed previously put forward its smart insulin pump, the mylife Loop, for a combined diabetes management system alongside Abbott’s FreeStyle Libre 3 continuous glucose monitor and the CamAPS ...

For over 20 years, Betsy Chadwell carried her insulin pens everywhere. Day in and day out, she carefully calibrated the doses needed to keep her Type 2 diabetes in check.